125 related articles for article (PubMed ID: 7666115)
1. Determination of the susceptibility in vitro of 54 isolates of Mycobacterium fortuitum against three fluoroquinolones using two methods.
Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
J Chemother; 1995 Apr; 7(2):109-13. PubMed ID: 7666115
[TBL] [Abstract][Full Text] [Related]
2. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents.
Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
J Chemother; 1995 Dec; 7(6):503-8. PubMed ID: 8667033
[TBL] [Abstract][Full Text] [Related]
3. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
4. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
[TBL] [Abstract][Full Text] [Related]
5. [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
Yamane N; Chilima BZ; Tosaka M; Okazawa Y; Tanno K
Kekkaku; 1996 Aug; 71(8):453-8. PubMed ID: 8831190
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Texier-Maugein J; Mormède M; Fourche J; Bébéar C
Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
Kawahara S; Tada A; Nagare H
Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
Hu BS; Fung CP; Liu PY; Lau YJ; Shi ZY; Lin YH
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
[TBL] [Abstract][Full Text] [Related]
10. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
[TBL] [Abstract][Full Text] [Related]
11. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
[TBL] [Abstract][Full Text] [Related]
12. Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.
Salfinger M; Hohl P; Kafader FM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():55-63. PubMed ID: 3144550
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
15. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Poiată A; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
Piersimoni C; Morbiducci V; Bornigia S; De Sio G; Scalise G
Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738
[TBL] [Abstract][Full Text] [Related]
17. [In vitro antimycobacterial activity of a new quinolone, NM394].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria.
Brown-Elliott BA; Wallace RJ; Crist CJ; Mann L; Wilson RW
Antimicrob Agents Chemother; 2002 Oct; 46(10):3283-5. PubMed ID: 12234861
[TBL] [Abstract][Full Text] [Related]
20. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
